tiprankstipranks
Trending News
More News >
CytoDyn (CYDY)
OTHER OTC:CYDY
US Market

CytoDyn (CYDY) Income Statement

Compare
686 Followers

CytoDyn Income Statement

Last quarter (Q1 2026), CytoDyn's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, CytoDyn's net income was $-5.54M. See CytoDyn’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ -5.92M$ 0.00$ 0.00$ 266.00K$ 0.00
Gross Profit
$ -18.00K$ -29.00K$ -175.00K$ 213.00K$ -1.80M
Operating Expenses
$ -11.34M$ 18.06M$ 40.40M$ 72.13M$ 92.75M
Depreciation and Amortization
$ 18.00K$ 29.00K$ 175.00K$ 781.00K$ 1.80M
EBITDA
$ 8.62M$ -18.03M$ -40.40M$ -194.97M$ -92.75M
Operating Income
$ 11.32M$ -18.06M$ -40.58M$ -145.40M$ -104.60M
Other Income/Expenses
$ -7.58M$ -31.78M$ -39.25M$ -65.42M$ -50.08M
Pretax Income
$ 3.75M$ -49.84M$ -79.82M$ -210.82M$ -154.67M
Net Income
$ 3.75M$ -49.84M$ -79.82M$ -210.82M$ -174.02M
Per Share Metrics
Basic EPS
$ 0.00$ -0.05$ -0.10$ -0.43$ -0.30
Diluted EPS
$ 0.00$ -0.05$ -0.10$ -0.43$ -0.30
Weighted Average Shares Outstanding
1.21B 969.51M 836.53M 676.90M 587.59M
Weighted Average Shares Outstanding (Diluted)
1.24B 969.51M 836.53M 676.90M 587.59M
Currency in USD

CytoDyn Earnings and Revenue History